YAZ: Birth Control Lawsuits Suggest Stronger Warning Labels Necessary

Yaz or Yasmin has now been linked to the deaths of at least 23 Canadian women, over half of which were under the age of 26.  In addition, over 600 adverse reactions to Yaz and Yasmin were reported between 2007 and February of 2013.  Although the FDA ordered clot risks to be added to some birth control labels, the drugs are still in circulation by their manufacturer, Bayer.  An estimated three in 10,000 women who have tried the “new-generation” birth control pills will develop blood clots, which are three times the risk taken by women using more traditional contraceptives, according to Health Canada.  The risk of blood clots in women taking birth controls has always been a factor; however drugs such as Yaz and Yasmin contain Drospirenone, which is a synthetic progestin that increases the risk.

Regulators are now considering ordering additional warning labels specific to the increased risks of blood clots, heart attacks, strokes and blockages in lungs or blood vessels, which can be fatal.  Bayer continues to allege that its own studies have shown no difference in blood clot risk between various birth control methods, although independent studies suggest the risk with Yaz and similar medications is slightly higher.

Over 4,000 lawsuits have been filed against Bayer arguing that any additional risk with the newer drugs should have been not only detected, but emphasized to the public.  If you or a loved one has been affected by Yaz, please contact an attorney knowledgeable in these types of mass tort claims.